Morningstar (MORN) stock outlook for 2026. A qualitative deep dive into recurring subscription revenue and brand trust, PitchBook's structural growth in private-market data, DBRS credit-rating issuance sensitivity, competition from FactSet, Bloomberg, S&P Global, and MSCI, and exposure to the asset-management cycle.
Jazz Pharmaceuticals (NASDAQ: JAZZ) 2026 stock outlook. A qualitative deep dive into the Xywav low-sodium conversion strategy, Epidiolex epilepsy growth, the Rylaze and Zepzelca oncology mix, the oxybate patent cliff, Avadel's Lumryz threat, and acquisition-driven growth with leverage risk.
MEDP (Medpace Holdings) 2026 stock outlook. A qualitative deep dive into the founder-led, single-integrated full-service CRO built for small and mid-cap biotech, its high margins and book-to-bill engine, and why net new business awards and backlog swing with the biotech funding cycle, benchmarked against IQVIA, ICON, and Charles River.
Group 1 Automotive (GPI) 2026 stock outlook. A deep look at the high-margin Parts and Service annuity, F&I economics, new and used vehicle GPU normalization, UK expansion, dealer M&A roll-up, the EV service debate, and how GPI stacks up against AutoNation, Penske, Lithia and Asbury for long-term investors.
WCC (Wesco International) 2026 stock outlook. A deep qualitative look at the EES, CSS, and UBS segments, the Anixter integration, data center and grid electrification and reshoring demand, and the distribution scale and switching-cost moat versus cyclicality, thin margins, and debt and rate risk.
Owens Corning (OC) 2026 stock analysis: the recurring re-roofing demand behind asphalt shingles, the energy-efficiency structural growth in fiberglass insulation, the new Doors segment from the 2024 Masonite acquisition, the composites divestiture that sharpens a high-margin building-products profile, strong free cash flow with buybacks and a dividend, and the US housing new-build and remodel cycle risk that still hangs over the story.
NVR Inc (NYSE: NVR) 2026 stock outlook. A qualitative deep dive into the lot-option asset-light land model, Ryan Homes brand strength, NVR Mortgage vertical integration, the no-dividend buyback compounding engine, and the rate, affordability, and ultra-high-share-price risks investors need to weigh.
Taewoong 044490 stock outlook 2026 for international investors: a Korean free-forging specialist supplying wind tower flanges and main shafts, an early SMR forged-component contract for a 300MW Canadian reactor, plus the order volatility, steel-plate cost, and CAPEX-cycle risks that define this KOSDAQ name.
Songwon Industrial (KOSPI 004430) 2026 stock outlook. A deep qualitative look at the global No. 2 polymer antioxidant oligopoly, tin and PVC stabilizers plus specialty chemicals, certification-based switching costs, phenol feedstock spread swings, cyclical thin margins, the comparison with BASF, and a Korea-stock cyclical value lens.
A 2026 stock outlook for Cosmo Chemical (KOSPI 005420), Korea's only titanium dioxide (TiO2) producer. We weigh its domestic monopoly cash cow against a Chinese-driven price war and loss cycle, plus the battery-materials and spent-battery recycling growth option tied to affiliate Cosmo Advanced Materials.
Gravity Co. (NASDAQ: GRVY / KOSDAQ: 117730) 2026 stock analysis for global investors: the Ragnarok Online single-IP global long tail across Southeast Asia, Taiwan, and Japan in 91 countries, the mobile-remake-licensing revenue engine, the console Ragnarok project targeting 2027, and the single-IP dependence, hit-driven volatility, small-cap liquidity, and dual-listing dynamics that define this game publisher.
Manyo Factory (KOSDAQ 439090) 2026 stock outlook. A qualitative deep dive into its vegan clean-beauty brand equity and Pure Cleansing Oil hero product, Japan, US and Southeast Asia export channels, asset-light ODM model, reliance on distributors like Silicon2, and marketing-spend and beauty-trend risks for global investors.
A qualitative 2026 outlook on Wontech (KOSDAQ 336570), the Korean energy-based aesthetic device maker behind Oligio monopolar RF and Picocare picosecond lasers. We dissect the razor-blade model of device sales plus recurring tip and cartridge consumables, export expansion across Asia, Europe, the Middle East and Latin America, rivalry with Classys, Jeisys Medical and Lutronic, and the discretionary aesthetic spending risk for Korea-focused investors.
i-SENS (099190) 2026 stock outlook. A deep qualitative look at the self-monitoring blood glucose (BGM) cash cow, the continuous glucose monitor (CGM) localization and reimbursement growth option, the electrochemical biosensor platform, overseas OEM supply, competition from Abbott Libre and Dexcom, CGM investment losses, and currency risk.
Korea Electric Terminal (KET, KOSPI 025540) 2026 stock outlook. A deep, qualitative look at rising connector content per vehicle from automotive electrification, EV high-voltage and high-speed data connectors, ADAS growth, and the offsetting risks of Hyundai-Kia customer concentration, a low-PBR discount, and global rivals like TE Connectivity, Aptiv, Molex and Yazaki.
LX Hausys (KRX 108670) 2026 stock outlook. A qualitative deep dive into its building-materials portfolio (PF insulation, PVC and aluminum windows, flooring, decorative film, HIMACS solid surface) plus auto materials and industrial film, its leverage to Korea's housing transaction and remodeling cycle, PVC and crude-oil spread margin sensitivity, and the tension between structural B2B premium growth and a soft domestic construction market.
TES (KOSDAQ 095610) 2026 stock outlook. A deep, qualitative look at its PECVD deposition and gas-phase etch and cleaning equipment, exposure to Samsung and SK Hynix CAPEX cycles, HBM and leading-edge tailwinds, customer concentration, equipment-stock volatility, and Chinese competition.
A practical 2026 walkthrough of the federal R&D tax credit (Section 41) and Section 174 R&E capitalization. Covers the four-part test, qualified research expenses, the startup payroll-tax offset, and the post-OBBBA return to immediate expensing.
A practical 2026 guide to S-corp reasonable compensation. How the salary vs distribution split cuts FICA payroll tax, how the IRS and courts judge reasonableness, why the 60/40 rule is a myth, audit red flags, and how QBI and retirement plans change the math for owner-employees.
A practical 2026 guide to vacant and unoccupied property insurance in the US. Learn why the vacancy clause (30 to 60 days) voids a standard homeowners or landlord policy, what vacant dwelling coverage and builders risk actually pay for, real cost ranges versus a standard policy, when landlords, investors, and estates need it, how to buy it, and the mistakes that get claims denied.
A practical 2026 guide to guaranteed issue life insurance for U.S. seniors. Learn how no-medical-exam whole life works, why the graded death benefit and 2-3 year waiting period matter, real monthly cost ranges by age and coverage, how it compares to simplified issue and fully underwritten policies, and the sales traps to avoid.
A practical 2026 guide to LHWCA claims for U.S. dockworkers, longshoremen, ship repairers, and shipbuilders. Covers the situs and status coverage tests, how the LHWCA differs from the Jones Act and state workers' comp, benefit types, the Section 905(b) vessel-negligence claim, the claims and appeals process, and how to choose an attorney.
A practical U.S. guide to refinery and chemical-plant explosion and burn injury lawsuits. Learn why workers' comp alone leaves money on the table, who you can actually sue as a third party (contractors, equipment makers, site owners), OSHA's role, negligence versus gross negligence, how burn damages are calculated, the claim timeline, and how contingency-fee lawyers work.
FIS (Fidelity National Information Services) stock outlook for 2026. A deep look at the core-banking switching-cost moat, the Worldpay separation and capital reshuffle, recurring revenue and buybacks, Fiserv and Global Payments rivalry, and the stagnation-versus-fintech-disruption debate.